Pharmacokinetics and Safety of DWJ1451 in Healthy Adults

An Open-label, Randomized, 2x2 Crossover Study to Compare the Pharmacokinetics and Safety Following Administration of DWJ1451 and Co-administration of DWC202008 and DWC202009 in Healthy Volunteers

Amlodipine, olmesartan, total ezetimibe, rosuvastatin AUCt, Cmax

Inclusion Criteria:

• Age 19 to 55 years
• Healthy Adult

Exclusion Criteria:

• Non-Healthy